910627-26-8
910627-26-8
Chemical Structure
CMX-2043
- CAS No.: 910627-26-8
- Formula:C16H26N2O6S2
- Molecular Weight:406.52
IUPAC Name: (S)-4-(5-((R)-1,2-dithiolan-3-yl)pentanamido)-5-(((S)-1-carboxyethyl)amino)-5-oxopentanoic acid
InChIKey: MQXRTCVZPIHBLD-TUAOUCFPSA-N
SMILES: C[C@H](NC([C@@H](NC(CCCC[C@H]1SSCC1)=O)CCC(O)=O)=O)C(O)=O
Biological Activity: CMX-2043 is a novel analogue of α-Lipoic Acid (HY-N0492). CMX-2043 is effective in antioxidant effect, activation of insulin receptor kinase, soluble tyrosine kinase, and Akt phosphorylation. CMX-2043 shows protection against ischemia-reperfusion injury (IRI) in rat model[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CMX-2043 | 98.80% | CMX-2043 is a novel analogue of α-Lipoic Acid (HY-N0492). CMX-2043 is effective in antioxidant effect, activation of insulin receptor kinase, soluble tyrosine kinase, and Akt phosphorylation. CMX-2043 shows protection against ischemia-reperfusion injury (IRI) in rat model. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
